Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on: January 23,2024

Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on:January 23,2024

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Updated on: February 19,2024

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Updated on:February 19,2024

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e

Updated on: January 23,2024

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e

Updated on:January 23,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on: April 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on:April 20,2024

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on: December 28,2023

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on:December 28,2023

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on: January 30,2024

Study finds a possible explanation for why immunotherapy works well for some cancer patients, but not others

by Yale UniversityCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0686Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack muta

Updated on:January 30,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on: May 13,2024

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion

Updated on:May 13,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on: January 22,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on:January 22,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on: January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on:January 26,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on: July 04,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on:July 04,2024